Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PROBAS-Study: Developing a Process-based and Modular Group Therapy for Acute Psychiatric Patients With Psychotic Symptoms: a Single-arm Feasibility Study

NCT04874974 is registered in ClinicalTrials.gov with Max-Planck-Institute of Psychiatry as lead sponsor.

NCT NCT04874974
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04874974 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PROBAS-Study: Developing a Process-based and Modular Group Therapy for Acute Psychiatric Patients With Psychotic Symptoms: a Single-arm Feasibility Study
Lead sponsor
Max-Planck-Institute of Psychiatry
Phase
Not applicable
Overall status
Completed
Start date
May 10, 2021
Completion date
September 23, 2023
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, current episode depressed, severe, with psychotic features, bipolar disorder, current episode manic severe with psychotic features, brief psychotic disorder, delusional disorder, major depressive disorder, recurrent, severe with psychotic symptoms, major depressive disorder, single episode, severe with psychotic features, manic episode, severe with psychotic symptoms, other psychotic disorder not due to a substance or known physiological condition, schizoaffective disorder, schizophrenia, schizotypal disorder, shared psychotic disorder, unspecified psychosis not due to a substance or known physiological condition